449 related articles for article (PubMed ID: 18313706)
1. Towards understanding the pathology of erythema nodosum leprosum.
Kahawita IP; Lockwood DN
Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):329-37. PubMed ID: 18313706
[TBL] [Abstract][Full Text] [Related]
2. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
[TBL] [Abstract][Full Text] [Related]
3. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
4. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
5. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
[TBL] [Abstract][Full Text] [Related]
7. Erythema Nodosum Leprosum Neutrophil Subset Expressing IL-10R1 Transmigrates into Skin Lesions and Responds to IL-10.
Pacheco FS; Prata RBDS; Brandão SS; Ferreira H; Rodrigues TF; Brandão Dos Santos J; da Silva CO; Tavares IF; Mendes MA; Rodrigues ACDP; Machado AM; Nery JADC; Amadeu TP; Moraes MO; Sarno EN; Schmitz V
Immunohorizons; 2020 Feb; 4(2):47-56. PubMed ID: 32034084
[TBL] [Abstract][Full Text] [Related]
8. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
9. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
Foss NT; de Oliveira EB; Silva CL
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
[TBL] [Abstract][Full Text] [Related]
10. Expression of B7-1 costimulatory molecules in patients with multibacillary leprosy and reactional states.
Santos DO; Castro HC; Bourguignon SC; Bastos OM; Rodrigues CR; Van Heuverswyn H; Nery JA; Miranda A
Clin Exp Dermatol; 2007 Jan; 32(1):75-80. PubMed ID: 17305909
[TBL] [Abstract][Full Text] [Related]
11. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
12. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
[TBL] [Abstract][Full Text] [Related]
13. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.
Moraes MO; Sampaio EP; Nery JA; Saraiva BC; Alvarenga FB; Sarno EN
Br J Dermatol; 2001 Jan; 144(1):175-81. PubMed ID: 11167702
[TBL] [Abstract][Full Text] [Related]
14. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
[TBL] [Abstract][Full Text] [Related]
15. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
Benard G; Sakai-Valente NY; Bianconcini Trindade MA
Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes and antibody levels in blisters over human leprosy skin lesions with or without erythema nodosum leprosum.
Scollard DM; Bhoopat L; Kestens L; Vanham G; Douglas JT; Moad J
Clin Immunol Immunopathol; 1992 Jun; 63(3):230-6. PubMed ID: 1623643
[TBL] [Abstract][Full Text] [Related]
17. A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum.
Filley E; Andreoli A; Steele J; Waters M; Wagner D; Nelson D; Tung K; Rademacher T; Dwek R; Rook GA
Clin Exp Immunol; 1989 Jun; 76(3):343-7. PubMed ID: 2787714
[TBL] [Abstract][Full Text] [Related]
18. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.
Chakrabarty AK; Kashyap A; Sehgal VN; Saha K
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112
[TBL] [Abstract][Full Text] [Related]
19. Erythema nodosum leprosum in histoid leprosy: a case report.
Kumar V; Mendiratta V; Sharma RC; Kakar N; Bajaj P
J Dermatol; 1997 Sep; 24(9):611-4. PubMed ID: 9350110
[TBL] [Abstract][Full Text] [Related]
20. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
Rea TH
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
